| Ticker Details |
|
Precision BioSciences, Inc.
|
| IPO Date: |
May 25, 2019 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$244.27M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.27 | 4.18%
|
| Avg Daily Range (30 D): |
$0.28 | 3.50%
|
| Avg Daily Range (90 D): |
$0.28 | 3.76%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.6M |
| Avg Daily Volume (30 D): |
.27M |
| Avg Daily Volume (90 D): |
.31M |
| Trade Size |
| Avg Trade Size (Sh.): |
169 |
| Avg Trade Size (Sh.) (30 D): |
67 |
| Avg Trade Size (Sh.) (90 D): |
71 |
| Institutional Trades |
| Total Institutional Trades: |
336 |
| Avg Institutional Trade: |
$1.43M |
| Avg Institutional Trade (30 D): |
$.75M |
| Avg Institutional Trade (90 D): |
$2.23M |
| Avg Institutional Trade Volume: |
.02M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.59M |
| Avg Closing Trade (30 D): |
$13.99M |
| Avg Closing Trade (90 D): |
$4.13M |
| Avg Closing Volume: |
19.72K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-1.28
|
$-1.26
|
$-.75
|
|
Diluted EPS
|
$-1.28
|
$-1.26
|
$-.75
|
|
Revenue
|
$45.06M
|
$M
|
$10.84M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-52.73M
|
$-32.65M
|
$-18.44M
|
|
Operating Income / Loss
|
$-36.4M
|
$-19.16M
|
$-9.08M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$27.6M
|
$-13.44M
|
$-11.31M
|
|
PE Ratio
|
|
|
|
|
|
|